| 1st Aug 2017 7:00 am |
RNS |
BTD for AZ's acalabrutinib in mantle cell lymphoma |
| 31st Jul 2017 7:00 am |
RNS |
Imfinzi granted BTD by US FDA for Stage III nsclc |
| 28th Jul 2017 11:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2017 7:15 am |
RNS |
Tagrisso significantly improves FLAURA |
| 27th Jul 2017 7:11 am |
RNS |
AZ reports initial results from MYSTIC lung trial |
| 27th Jul 2017 7:06 am |
RNS |
AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL |
| 27th Jul 2017 7:00 am |
RNS |
AstraZeneca PLC - H1 2017 Results |
| 26th Jul 2017 4:46 pm |
RNS |
Faslodex receives EU approval for 1L breast cancer |
| 21st Jul 2017 3:45 pm |
RNS |
Holding(s) in Company |
| 3rd Jul 2017 2:59 pm |
RNS |
Total Voting Rights |
| 3rd Jul 2017 7:00 am |
RNS |
AZ COMPLETES SELOKEN AGREEMENT WITH RECORDATI |
| 3rd Jul 2017 7:00 am |
RNS |
AZ COMPLETES ZOMIG DIVESTMENT WITH GRÜNENTHAL |
| 23rd Jun 2017 12:46 pm |
RNS |
Faslodex CHMP positive opinion in 1L breast cancer |
| 7th Jun 2017 7:13 am |
RNS |
AZ agreement with Grünenthal for rights to Zomig |
| 6th Jun 2017 7:00 am |
RNS |
ASTRAZENECA PRICES A $2BN BOND ISSUE |
| 5th Jun 2017 7:00 am |
RNS |
LYNPARZA: SIGNIFICANT PFS IN BRCAm BREAST CANCER |
| 1st Jun 2017 3:00 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2017 3:00 pm |
RNS |
Total Voting Rights |
| 31st May 2017 7:00 am |
RNS |
Directorate Change |
| 24th May 2017 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 23rd May 2017 7:00 am |
RNS |
Bydureon EXSCEL trial meets T2D safety objective |
| 22nd May 2017 7:00 am |
RNS |
AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE |
| 16th May 2017 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th May 2017 7:00 am |
RNS |
IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER |
| 10th May 2017 7:00 am |
RNS |
AZ updates on tralokinumab trial in severe asthma |
| 2nd May 2017 2:00 pm |
RNS |
Total Voting Rights |
| 2nd May 2017 7:00 am |
RNS |
DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL |
| 27th Apr 2017 5:30 pm |
RNS |
Result of AGM |
| 27th Apr 2017 7:00 am |
RNS |
AstraZeneca: Q1 2017 Results |
| 25th Apr 2017 1:30 pm |
RNS |
TAGRISSO RECEIVES FULL APPROVAL IN THE EU |
| 12th Apr 2017 5:34 pm |
RNS |
Notification of Major Interest in Shares |
| 3rd Apr 2017 3:00 pm |
RNS |
Total Voting Rights |
| 31st Mar 2017 7:01 am |
RNS |
Tagrisso (osimertinib) receives FDA full approval |
| 31st Mar 2017 7:00 am |
RNS |
AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICS |
| 28th Mar 2017 4:00 pm |
RNS |
Director/PDMR Shareholding |
| 27th Mar 2017 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 17th Mar 2017 7:00 am |
RNS |
US FDA issues CRL for ZS-9 in hyperkalaemia |
| 16th Mar 2017 11:00 am |
RNS |
Notice of AGM |
| 15th Mar 2017 7:00 am |
RNS |
LYNPARZA PFS IN BRCA OVARIAN MAINTENANCE THERAPY |
| 8th Mar 2017 7:00 am |
RNS |
Filing of Form 20-F with SEC |
